Leerink Partnrs Has Bullish Estimate for CNTA Q2 Earnings
Centessa Pharmaceuticals plc (NASDAQ:CNTA – Free Report) – Investment analysts at Leerink Partnrs boosted their Q2 2025 earnings per share (EPS) estimates for Centessa Pharmaceuticals in a research report issued to clients and investors on Wednesday, May 14th. Leerink Partnrs analyst D. Risinger now anticipates that the company will post earnings per share of ($0.35) […]
Centessa Pharmaceuticals plc (NASDAQ:CNTA – Free Report) – Investment analysts at Leerink Partnrs boosted their Q2 2025 earnings per share (EPS) estimates for Centessa Pharmaceuticals in a research report issued to clients and investors on Wednesday, May 14th. Leerink Partnrs analyst D. Risinger now anticipates that the company will post earnings per share of ($0.35) […]
